Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Urogen Pharma Ltd (URGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Urogen Pharma Ltd 499 Park Avenue New York NY 10014 USA

P: 646-768-9780

Description:

UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.

Key Statistics

Overview:

Market Capitalization, $K 502,187
Shares Outstanding, K 13,751
Annual Sales, $ 1,130 K
Annual Net Income, $ -75,660 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,720 K
60-Month Beta 1.33
% of Insider Shareholders 10.50%
% of Institutional Shareholders 81.77%
Float, K 12,307
% Float 89.50%

Growth:

1-Year Return -39.62%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/09/19
Earnings Per Share ttm -4.76
EPS Growth vs. Prev Qtr 23.97%
EPS Growth vs. Prev Year -26.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

URGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -11.78
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -61.24
Return-on-Assets (Before Tax) -56.79
Profit Margin % -6,695.58
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 457.88
Price/Cash Flow N/A
Price/Book 2.16
Book Value/Share 6.55
Interest Coverage -46.78
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar